↓ Skip to main content

Twelve Years' Experience with Direct-to-Consumer Advertising of Prescription Drugs in Canada: A Cautionary Tale

Overview of attention for article published in PLOS ONE, May 2009
Altmetric Badge

Mentioned by

twitter
3 X users

Citations

dimensions_citation
29 Dimensions

Readers on

mendeley
54 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Twelve Years' Experience with Direct-to-Consumer Advertising of Prescription Drugs in Canada: A Cautionary Tale
Published in
PLOS ONE, May 2009
DOI 10.1371/journal.pone.0005699
Pubmed ID
Authors

Barbara Mintzes, Steve Morgan, James M. Wright

Abstract

Direct-to-consumer advertising (DTCA) of prescription drugs is illegal in Canada as a health protection measure, but is permitted in the United States. However, in 2000, Canadian policy was changed to allow 'reminder' advertising of prescription drugs. This is a form of advertising that states the brand name without health claims. 'Reminder' advertising is prohibited in the US for drugs that have 'black box' warnings of serious risks. This study examines spending on DTCA in Canada from 1995 to 2006, 12 years spanning this policy shift. We ask how annual per capita spending compares to that in the US, and whether drugs with Canadian or US regulatory safety warnings are advertised to the Canadian public in reminder advertising.

X Demographics

X Demographics

The data shown below were collected from the profiles of 3 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 54 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United Kingdom 1 2%
Unknown 53 98%

Demographic breakdown

Readers by professional status Count As %
Student > Master 14 26%
Student > Bachelor 7 13%
Researcher 6 11%
Student > Ph. D. Student 6 11%
Professor > Associate Professor 4 7%
Other 8 15%
Unknown 9 17%
Readers by discipline Count As %
Medicine and Dentistry 10 19%
Social Sciences 6 11%
Business, Management and Accounting 5 9%
Psychology 5 9%
Pharmacology, Toxicology and Pharmaceutical Science 4 7%
Other 11 20%
Unknown 13 24%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 24 March 2017.
All research outputs
#16,302,882
of 25,743,152 outputs
Outputs from PLOS ONE
#145,310
of 224,233 outputs
Outputs of similar age
#104,145
of 123,484 outputs
Outputs of similar age from PLOS ONE
#425
of 511 outputs
Altmetric has tracked 25,743,152 research outputs across all sources so far. This one is in the 34th percentile – i.e., 34% of other outputs scored the same or lower than it.
So far Altmetric has tracked 224,233 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 15.8. This one is in the 32nd percentile – i.e., 32% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 123,484 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 14th percentile – i.e., 14% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 511 others from the same source and published within six weeks on either side of this one. This one is in the 16th percentile – i.e., 16% of its contemporaries scored the same or lower than it.